Kore Private Wealth’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-268	Closed	-$19K	–	446
2020 Q2	$19K	Buy	+268	New	+$19K	﹤0.01%	652
2019 Q2	–	Sell	-742	Closed	-$27K	–	350
2019 Q1	$27K	Sell	742 -1,000	-57%	-$36.4K	0.01%	470
2018 Q4	$50K	Buy	+1,742	New	+$50K	0.01%	370